Oct 072020
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, CA –  Federation Bio, a microbial therapeutics company targeting diseases in which the human microbiome can play a curative role, today announced that it has closed a $50 million Series A financing led by Horizons Ventures and joined by existing investors Venrock and Altitude, and additional new investors ...

Federation Bio appoints Dr. Emily Drabant Conley to its Board as CEO alongside Dr. John Stuelpnagel joining as Board member, and announces $50m Series A financing led by Horizons Ventures

Federation Bio appoints Dr. Emily Drabant Conley to its Board as CEO alongside Dr. John Stuelpnagel joining as Board member, and announces $50m Series A financing led by Horizons Ventures

From:: Federation Bio appoints Dr. Emily Drabant Conley to its Board as CEO alongside Dr. John Stuelpnagel joining as Board member, and announces $50m Series A financing led by Horizons Ventures

Sorry, the comment form is closed at this time.